AVAnja Vaskinn

Anja Vaskinn

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Anja Vaskinn has a total of 212 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The Double Standards of the Association for the Treatment and Prevention of Sexual Abuse (ATSA)

    by Anja Vaskinn

    The Association for the Treatment and Prevention of Sexual Abuse ( ATSA ) is an organization for researchers and clinicians in the field concerned with treatment and understanding of individuals who have committed sexual abuse or are at risk of committing sexual abuse. ATSA ’s annual conference for 2025 takes place at a SeaWorld hotel, a choice which stands in contrast to ATSA ’s mission of preventing abuse. This commentary reviews the history of animal exploitation and ongoing maltreatment that enable the continued public display of animals at oceanaria such as SeaWorld. The scientific evidence of an overlap and similarities between violence and abuse against human and nonhuman animals is summarized, highlighting how abuse of nonhuman animals is not without relevance for ATSA ’s members. Choosing a conference venue affiliated with abuse and exploitation of nonhuman animals unveils the double standards of an organization whose mission is to prevent abuse.

  • Open Access

    Social cognitive training among individuals with schizophrenia: Identifying responders to treatment

    by Anja Vaskinn, André Løvgren, Ole A. Andreassen, Kjetil Sundet

  • Open Access

    The startle response and prepulse inhibition in psychosis and violence: A combined electromyography and electroencephalography study

    by Nina Bang, Johanne H Pettersen, Merete Berg Nesset, Kirsten Rasmussen, Hilde Dahl, Natalia Tesli, Christina Bell, Anja Vaskinn, Thomas Fischer-Vieler, Christine Friestad, et al.

    There is a pressing need for biomarkers of violent behavior risk in psychosis. Previous research indicates that electrophysiological measures of automatic defensive reactions may have potential. The purpose of this study was to investigate associations between violent behavior in individuals with and without psychosis and electromyography (EMG) and electroencephalography (EEG) responses to startling auditory stimuli. EMG and EEG was recorded during an auditory startle paradigm from healthy controls (HC, n=211), individuals with psychosis and a history of violent behavior (violent-PSY, n=18), individuals with psychosis without a history of violence (nonviolent-PSY, n=32), and individuals with a history of violence without psychosis (violent non-PSY, n=22). We estimated the auditory startle response (ASR) and prepulse inhibition (PPI) using EMG (i.e., EMGASR and EMGPPI) and the auditory evoked potential (i.e., AEPASR and AEPPPI) of the EEG. There were no significant effects of group on the EMGASR (p = 0.10) or the 30-ms, 60-ms, and 120-ms prepulse + pulse EMGPPI amplitudes (p = 0.11, p = 0.19, and p = 0.50, respectively). The N1 amplitude of the AEPASR was reduced in the violent-PSY group (p = <.001) and the nonviolent-PSY group (p = .015) compared to HC. The P2 amplitude of the AEPASR was reduced in violent-PSY relative to nonviolent-PSY (p = .003), violent non-PSY (p = .016), and HC (p < .001). Together, these results show that EEG-based neural responses to startling auditory stimuli are promising biomarkers of violence risk in psychosis.

  • Open Access

    Longitudinal course of inflammatory-cognitive subgroups across first treatment severe mental illness and healthy controls

    by Linn Sofie Sæther, Thor Ueland, Beathe Haatveit, Anja Vaskinn, Camilla Bärthel Flaaten, Christine Mohn, Monica B. E.G. Ormerod, Pål Aukrust, Ingrid Melle, Nils Eiel Steen, et al.

    Background: While inflammation is associated with cognitive impairment in severe mental illnesses (SMI), there is substantial heterogeneity and evidence of transdiagnostic subgroups across schizophrenia (SZ) and bipolar (BD) spectrum disorders. There is however, limited knowledge about the longitudinal course of this relationship.Methods: Systemic inflammation (C-Reactive Protein, CRP) and cognition (nine cognitive domains) was measured from baseline to 1 year follow-up in first treatment SZ and BD (n = 221), and healthy controls (HC, n = 220). Linear mixed models were used to evaluate longitudinal changes separately in CRP and cognitive domains specific to diagnostic status (SZ, BD, HC). Hierarchical clustering was applied on the entire sample to investigate the longitudinal course of transdiagnostic inflammatory-cognitive subgroups.Results: There were no case-control differences or change in CRP from baseline to follow-up. We confirm previous observations of case-control differences in cognition at both time-points and domain specific stability/improvement over time regardless of diagnostic status. We identified transdiagnostic inflammatory-cognitive subgroups at baseline with differing demographics and clinical severity. Despite improvement in cognition, symptoms and functioning, the higher inflammation – lower cognition subgroup (75% SZ; 48% BD; 38% HC) had sustained inflammation and lower cognition, more symptoms, and lower functioning (SMI only) at follow-up. This was in comparison to a lower inflammation – higher cognition subgroup (25% SZ, 52% BD, 62% HC), where SMI participants showed cognitive functioning at HC level with a positive clinical course.Conclusions: Our findings support heterogenous and transdiagnostic inflammatory-cognitive subgroups that are stable over time, and may benefit from targeted interventions.


  • Open Access

    Longitudinal course of inflammatory-cognitive subgroups across first treatment severe mental illness and healthy controls

    by Linn Sofie Sæther, Thor Ueland, Beathe Haatveit, Anja Vaskinn, Camilla Bärthel Flaaten, Christine Mohn, Monica B. E.G. Ormerod, Pål Aukrust, Ingrid Melle, Nils Eiel Steen, et al.

    Background While inflammation is associated with cognitive impairment in severe mental illnesses (SMI), there is substantial heterogeneity and evidence of transdiagnostic subgroups across schizophrenia (SZ) and bipolar (BD) spectrum disorders. There is however, limited knowledge about the longitudinal course of this relationship. Methods Systemic inflammation (C-Reactive Protein, CRP) and cognition (nine cognitive domains) was measured from baseline to 1 year follow-up in first treatment SZ and BD (n=221), and healthy controls (HC, n=220). Linear mixed models were used to evaluate longitudinal changes separately in CRP and cognitive domains specific to diagnostic status (SZ, BD, HC). Hierarchical clustering was applied on the entire sample to investigate the longitudinal course of transdiagnostic inflammatory-cognitive subgroups. Results There were no case-control differences or change in CRP from baseline to follow-up. We confirm previous observations of case-control differences in cognition at both time-points and domain specific stability/improvement over time regardless of diagnostic status. We identified transdiagnostic inflammatory-cognitive subgroups at baseline with differing demographics and clinical severity. Despite improvement in cognition, symptoms and functioning, the higher inflammation – lower cognition subgroup (75% SZ; 48% BD; 38% HC) had sustained inflammation and lower cognition, more symptoms, and lower functioning (SMI only) at follow-up. This was in comparison to a lower inflammation – higher cognition subgroup (25% SZ, 52% BD, 62% HC), where SMI participants showed cognitive functioning at HC level with a positive clinical course. Conclusions Our findings support heterogenous and transdiagnostic inflammatory-cognitive subgroups that are stable over time, and may benefit from targeted interventions.

  • Open Access

    Sex differences in social cognition among individuals with schizophrenia and in healthy control participants: a secondary analysis of published data

    by Anja Vaskinn, Torill Ueland, Ingrid Melle, Kjetil Sundet

    Purpose: Sex differences are present among individuals experiencing schizophrenia. Whether these differences extend to social cognition is unclear. In this study, we investigated sex differences in emotion perception, social perception and theory of mind (ToM). Methods: We examined sex differences between males and females with schizophrenia on five social cognitive tests. Healthy male and female control participants were included to examine if any sex difference was illness-specific. Emotion perception was measured with Pictures of Facial Affect (PFA) and Emotion in Biological Motion (EmoBio); social perception with the Relationships Across Domains Test (RAD); and ToM with the Movie for the Assessment of Social Cognition (MASC) and Hinting Task. Results: Two-way analyses of variance revealed overall group differences for all tests, with healthy controls outperforming individuals with schizophrenia. Significant sex effects were present for PFA and Hinting Task. There were no significant interaction effects. Within-group independent samples t-tests yielded one significant sex difference, i.e., among healthy controls for PFA. Conclusions: Females had better facial emotion perception than males. This sex difference was statistically significant among healthy controls and medium-large among individuals experiencing schizophrenia. There were no significant sex differences for other social cognitive domains. The study did not find evidence for a general female advantage in social cognition.


  • Open Access

    Intra- and inter-individual cognitive variability in schizophrenia and bipolar spectrum disorder: an investigation across multiple cognitive domains

    by Beathe Haatveit, Lars T. Westlye, Anja Vaskinn, Camilla Bärthel Flaaten, Christine Mohn, Thomas Bjella, Linn Sofie Sæther, Kjetil Sundet, Ingrid Melle, Ole A. Andreassen, et al.

    There is substantial cognitive heterogeneity among patients with schizophrenia (SZ) and bipolar disorders (BD). More knowledge about the magnitude and clinical correlates of performance variability could improve our understanding of cognitive impairments. Using double generalized linear models (DGLMs) we investigated cognitive mean and variability differences between patients with SZ (n = 905) and BD spectrum disorders (n = 522), and healthy controls (HC,n = 1170) on twenty-two variables. The analysis revealed significant case-control differences on 90% of the variables. Compared to HC, patients showed larger intra-individual (within subject) variability across tests and larger inter-individual (between subject) variability in measures of fine-motor speed, mental processing speed, and inhibitory control (SZ and BD), and in verbal learning and memory and intellectual functioning (SZ). In SZ, we found that lager intra -and inter (on inhibitory control and speed functions) individual variability, was associated with lower functioning and more negative symptoms. Inter-individual variability on single measures of memory and intellectual function was additionally associated with disorganized and positive symptoms, and use of antidepressants. In BD, there were no within-subject associations with symptom severity. However, greater inter-individual variability (primarily on inhibitory control and speeded functions) was associated with lower functioning, more negative -and disorganized symptoms, earlier age at onset, longer duration of illness, and increased medication use. These results highlight larger individual differences in patients compared to controls on various cognitive domains. Further investigations of the causes and correlates of individual differences in cognitive function are warranted.